ISSCA Confirms Date for its First 2018 Fellowship in Cell Therapy and Tissue Engineering
The International Society for Stem Cell Application (ISSCA) has scheduled the first Cell Therapy and Tissue Engineering Fellowship in the upcoming year for March 5, 2018. The 6-day immersive program will be held in Seoul, Korea.
MIAMI, Nov. 9, 2017—The International Society for Stem Cell Application (ISSCA), a global leader in regenerative medicine education, research, and certification, will hold the first Cell Therapy and Tissue Engineering fellowship for the upcoming year on March 5, 2018, in Seoul, Korea.
Following up on the success of the organization’s series of fellowships in 2017, ISSCA decided to continue to offer the opportunity to graduate and post-doctoral students. Participants will engage with world-class stem cell and regenerative medicine experts in an immersive, hands-on experience focused on stem cell characterization and laboratory applications including cell culture, plating, trypsinization, harvesting, and cryopreservation. Fellowship attendants also gain an understanding of control tests including cell count, viability, flow cytometry, endotoxin, mycoplasma, and sterility.
“The very nature of stem cell therapy and tissue engineering necessitates practical, immersive, and skillfully monitored participation for students training in the application of stem cells,” says Benito Novas, ISSCA Public Relations Director and founder of Global Stem Cells Group. “The opportunity to actively engage while learning theoretical and analytical methods from mentors working to create new medical technologies and laboratory applications in one of the most rapidly growing areas of biomedical engineering is highly advantageous.
“Bio-medical scientists encounter many challenges before tissue engineering therapies reach clinical use and widespread application,” Novas says. “Cell therapy and tissue engineering offer vast potential for a career as a practitioner or researcher in which today’s students can be tomorrow’s pioneers in improving the efficacy of medical treatments and advancing the healthcare industry.”
And since so many tissues and organs are excellent candidates for engineering new treatments and cures for diseases, including blood vessel, bone, cartilage, liver, pancreas, peripheral nerve, and skin cells, the future of regenerative medicine has the potential to revolutionize disease remediation and tissue repair
The ISSCA Fellowship in Cell Therapy and Tissue Engineering is a 6-day workshop that offers a certificate of completion issued by ISSCA and Westminster International University in Seoul. Students who complete the fellowship become members of the ISSCA’s international network of regenerative medical professionals and standard setters, with access to events, resources, training, and support moving forward.
ISSCA is the only organization that provides a complete Cell Therapy and Engineering Tissue Fellowship focused on regenerative medicine. It is also the only fellowship of its kind supported by Korean Universities.
To learn more about the ISSCA fellowship and to reserve a spot at the March 8, 2018 program in Korea, visit http://stemcellsacademy.com, email info@stemcellsgroup.com, or call +1305 560 5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
###
.
ISSCA 2018 Korea Fellowship
- Published in Press Releases
ISSCA to Conduct Regenerative Medicine Certification Training for Physicians in Buenos Aires, Argentina November 26 – 27, 2017
The International Association for Stem Cell Application (ISSCA) will be conducting a regenerative medicine certification course for physicians in Buenos Aires Nov. 26-27, 2017. The two-day intensive training course teaches trainees extraction, isolation, and application of PRP, adipose, and bone marrow stem cells.
MIAMI, Nov. 9, 2017— The International Society for Stem Cell Application (ISSCA), a global leader in regenerative medicine training, has announced plans to conduct regenerative medicine certification training for physicians in Buenos Aires, Argentina November 26 – 27, 2017.
The ISSCA training course, available to qualified physicians interested in adding regenerative medicine to their practice procedures, provides hands-on, practical instruction under the guidance of trained medical experts in a highly visual, interactive, and clinical learning environment.
.ISSCA’s medical professionals teach reintegration and procedural techniques on live patients using different protocols for isolating stem cells. Trainees will participate in different medical cases under the supervision of trained specialists.
This hands-on stem cell training course provides each participant with a live demonstration of the extraction, isolation, and application of PRP, adipose, and bone marrow stem cells. Techniques and materials used in the course, along with high-resolution, step-by-step procedure videos are provided for the participating physician’s future use and reference.
Led by ISSCA’s established team of skilled practitioners, this course is designed specifically to provide personalized instruction. Seats for each course are limited to 8-10 trainees, not only to suit each participant’s individual training needs but also to allow for professional networking.
Participants who complete the training will receive certification that documents their participation in and completion of the training, their and their knowledge and skills in the field of regenerative medicine. Certification candidates are required to provide proof of prior medical training and experience, and successfully complete a written as well as an oral/practical exam. Certification confirms a physician’s expertise in regenerative medicine.
Certification procedures and requirements are key to the integrity of regenerative medicine. They furnish a reputable credential that is essential not only for patients to see, but also to a physician’s practice.
The Buenos Aires certification training course will mark the 11th event ISSCA has sponsored and hosted thus far in 2017. The organization is working to position itself as a reference point for regenerative medical practitioners worldwide. With a presence in more than 25 countries, physicians interested in certification can check for an ISSCA training course near them by visiting the https://www.stemcelltraining.net/ website, email info@stemcellsgroup.com, or call +1305 560 5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
. ###
Regenerative medicine certification training
- Published in Press Releases
AdiMarket, a division of Global Stem Cells Group, to sponsor American Academy of Anti-Aging Medicine (A4M) 25th Annual World Congress in Las Vegas Dec. 14 – 16, 2017
(Pictured at left) Integrated Stem Cell Work Station, a new multi-functional bio-work station from AdiMarket,
Adimarket, a division of Global Stem Cells Group announces its sponsorship of the 25th Annual American Academy of Anti-Aging Medicine (A4M) World Congress in Las Vegas Dec. 14-16. GSCG plans to launch two new products for stem cell and regenerative medicine practitioners at the event.
MIAMI, Nov. 9, 2017—Adimarket, a division of Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, announces its sponsorship of the 25th Annual American Academy of Anti-Aging Medicine (A4M) World Congress in Las Vegas, Dec. 14 – 16, 2017. This year marks a quarter-century in A4M’s mission to build awareness and deliver innovative, cutting-edge scientific education in the field of anti-aging medicine.
A4M focuses on longevity and prolonging the lifespan of people worldwide. Global Stem Cells Group shares A4M’s commitment to promoting anti-aging medicine, having organized five regenerative medicine symposiums and other medical conferences highlighting anti-aging research and therapies in 2017.
Global Stem Cells Group will leverage the large gathering of regenerative medicine and healthcare professionals at theInternational Congress to launch its newest cutting-edge online regenerative medicine training course in collaboration with StemCell Training, Inc.
The new virtual regenerative medicine training course is designed to instruct qualified physicians in the theoretical and practical protocols necessary to effectively and expertly administer regenerative medicine procedures to their patients. Training includes instructions for harvesting and isolating stem cells. The online training program positions physicians to provide stem cell procedures in their existing practice or open a stem cell center practice and join ISSCA’s international network of stem cell specialists.
GSCG will also launch two new products at the A4M conference:
- STEMPIA, a new adipose-derived stem cell kit. The kit provides two specially designed tubes to isolate and concentrate adipose tissue-derived stromal vascular fraction (SVF). STEMPIA offers an easier, more effective, and shorter process for SVF isolation while maintaining high viability rates. STEMPIA uses fewer consumables and tools compared to manual SVF isolation processes, saving both costs and time in the SVF isolation process.
- The latest Integrated Stem Cell Work Station from AdiMarket, a multi-functional bio-work station that allows physicians to perform stem cell protocols and procedures within an enclosed controlled culture environment. The Integrated Stem Cell Work Station is equipped with a built-in centrifuge, shaking incubator, laminar flow hood and other features to ensure a clean environment for stem cell isolation and handling. It can also be customized to accommodate insertion of supplementary device(s) in work station.
The American Academy of Anti-Aging Medicine (A4M) 25th Annual World Congress will be hosted at the Venetian and Palazzo Resort, a hotel and casino resort located on the Las Vegas Strip.
To learn more about the A4M World Congress, visit the event website. For more information about Global Stem Cells Group, visit the GSCG website, email info@stemcellsgroup.com, or call +1305 560 5337.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s aim is to be the largest recognized stem cell and regenerative medicine network in the world.
About Adimarket:
Adimarket, Inc., a division of the Global Stem Cells Group, is a one-stop, cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and healthcare professionals.
Adimarket was founded to provide practitioners the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact stem cell medicine can have when dispensed in a doctor’s office, Adimarket provides physicians with the tools they need to provide patients with cutting-edge treatments.
###
A4M 25th Annual World Congress
- Published in Press Releases
ISSCA Announces its Regenerative Medicine Conferences Agenda for 2018
The International Association for Stem Cell Application (ISSCA) has announced plans to host three regenerative medicine symposiums in Istanbul, Turkey, Buenos Aires, Argentina, and Seoul, Korea in 2018. The Seoul symposium will be part of, the 6th Annual International Conference of ISSCA, “Progress and Perspectives,” which will be held in Seoul in November 2018.
MIAMI, Nov. 9, 2017—The International Association for Stem Cell Application (ISSCA) has announced plans to host three regenerative medicine symposiums in the upcoming year:
- Istanbul, Turkey, April 2018
- Buenos Aires, Argentina, August 2018
- Seoul, Korea, November 2018
The symposium series will culminate in the 6th Annual International Conference of ISSCA, Progress and Perspectives, in Seoul, Korea in November 2018.
The three international symposiums are part of ISSCA’s mission to support a paradigm shift in healthcare from traditional to regenerative medicine in the 21st Century and provide cutting-edge information on developments in all areas of stem cell research. Each event will host a group of renowned international speakers in the field of stem cell and regenerative medicine, who will offer a day of rigorous scientific discourse aimed at physicians.
Each ISSCA symposium will incorporate the biology, medicine, applications, regulations, product development, and commercialization of stem cells. Business opportunities, challenges, and potential strategies for overcoming these challenges will also be addressed.
The central theme of each international symposium is as follows:
• Istanbul: Advances in Cell Therapies
• Buenos Aires: Next Generation Medicine: Adult Stem Cells
• Seoul: This seminar will be part of the 6th Annual International Conference of ISSCA, “Progress and Perspectives”
Symposium dates and details will be available shortly. To learn more about the ISSCA symposiums and 6th Annual International Conference of ISSCA, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
.###
Regenerative medicine symposiums 2018 ISSCA
- Published in Press Releases
Global Stem Cells Group Announces New Turn-Key Solution for Stem Cell Processing
Global Stem Cells Group and its affiliate AdiMarket announce the new Turn-Key Solution, a one-stop solution that provides high-quality stem cell processing equipment and kits and the expert help needed to set up a stem cell lab in-clinic or in-hospital.
MIAMI, Nov. 9, 2017—Global Stem Cells Group (GSCG) and its affiliate AdiMarket now offer a new, turn-key solution for stem cell processing. The AdiMarket Turn-Key Solution is a one-stop solution that provides high-quality equipment and kits required for stem cell processing and the expert help needed to set up a stem cell processing lab in-clinic or in-hospital. It can also be designed for complex protocols such as cryopreservation, culturing, and expansion of adult stem cells derived from adipose tissue and bone marrow.
GSCG and AdiMarket provide everything needed to bring this ready-to-go cell processing expansion lab to scientists andinstitutions worldwide. Physician training courses in the field of regenerative medicine are also available to qualified physicians. These expert training courses provide hands-on, practical instruction under the guidance of trained medical experts in a highly visual, interactive, and clinical learning environment.
The AdiMarket Turn-Key Solution is a complete solution for installing highly customized, in-clinic or in-hospital turn-key laboratories to meet each facility’s individual needs.
“A well-planned, organized, and properly equipped laboratory supports critical research and favorable procedure outcomes by increasing efficiency and reducing lost time and wasted resources,” says Benito Novas, Global Stem Cells Group founder and CEO. This is vital to continuing to the discovery and implementation of new methods for treating patients.”
Admarket is GSCG’s online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals, offering all the tools and products practitioners need to facilitate in-office, in-clinic, or in-hospital stem cell procedures. From planning to building the lab, to training and consultation, Turn-Key Solution users are equipped in every way possible to walk in and begin using their fully-outfitted biotechnology lab.
To learn more about Global Stem Cells Group and the AdiMarket Turn-Key Solution, visit the GSCG website, email info@stemcellsgroup.com, or call +1305 560 533
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s aim is to be the largest recognized stem cell and regenerative medicine network in the world.
About Adimarket:
Adimarket, Inc., a division of the Global Stem Cells Group, is a one-stop, cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and healthcare professionals.
Adimarket was founded to provide practitioners the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact stem cell medicine can have when dispensed in a doctor’s office, Adimarket provides physicians with the tools they need to provide patients with cutting-edge treatments.
###
Cell Processing urn-key solution
- Published in Press Releases
STEM CELL CENTER NETWORK TO OPEN NEW FACILITY IN WEST PALM BEACH
Mr Benito Novas
info@stemcellsgroup.com
+ 1 305 560 5337
West Palm Beach, FL – Stem Cell Center Network, the subsidiary entity of Global Stem Cells Group, an international network of doctors, educators, and practitioners all working to advance the study of regenerative medicine in our world today, this week excitedly announced as part of their effort to establish facilities on every continent, they are opening a new practice in West Palm Beach, Florida.
To integrate more than 15-doctors who have practiced regenerative medicine in the greater West Palm Beach area, these individuals will work together to help patients through regenerative medical practices.
“We have taken a preemptive approach to this office launch and have trained all of the members of this new center in the latest regenerative medicine techniques, as well as provided all of the necessary supplies and equipment that they need to launch a successful practice,” said Mr. Benito Novas, Founder and Owner of Global Stem Cells Group. “We take pride in the quality of equipment and medical infrastructure that we provide for all of our practitioners.”
This West Palm Beach facility will be the network’s fifth center located in the United States. It is the 30th office for the network worldwide, and confirms that Stem Cell Center Network is one of the largest regenerative medical networks functioning in the world today.
“We are a group that embodies the best and brightest regenerative medical minds available in the world today,” said Mr. Benito. “Everyone from Dr. Feinman to Dr. Purita, internationally regarded for their groundbreaking regenerative work, are part of the Global Stem Cells Group framework. Without our members, we wouldn’t be the kind of international network we have come to cultivate today. Spread the word on the official opening of our new center in West Palm Beach, and head on over to our website to learn more about our programs, courses, fellowships, and more.”
Every member of the Global Stem Cells Group network is required to keep in contact with other members, ensuring all new doctors feel welcomed and supported in their medical quests.
More information regarding the regenerative medicine network can be found at: http://stemcellcenter.net/.
- Published in Press Releases
MORE THAN 300 MARROQUIES DOCTORS ATTENDED THE 5TH INTERNATIONAL REGENERATIVE MEDICINE SYMPOSIUM IN MOROCCO
Mr Benito Novas
info@stemcellsgroup.com
+1305 560 5337
MORE THAN 300 MARROQUIES DOCTORS ATTENDED THE 5TH INTERNATIONAL REGENERATIVE MEDICINE SYMPOSIUM IN MOROCCO
Morocco – The 5th International Regenerative Medicine Symposium, organized and hosted by the International Society for Stem Cell Application (ISSCA), welcomed over 300 Marroquies doctors to the groundbreaking Moroccan event this past weekend.
The symposium, which officially took place on September 30 at the Hotel Sofitel Rabat in Morocco, welcomed attendees from around the world, including doctors from the U.S., Argentina, Morocco, India, Spain, and a plethora of other nations. The attendees came together to discuss the topic, “Outstanding challenge: Delivering the promise of stem cell therapies,” as well as listen to distinguished speakers share their findings and hopes for the future of regenerative medicine.
“As an organization that hosts multiple symposiums around the world every single year, we were absolutely elated to see so many Marroquies doctors in attendance at this constructive event,” said Mr. Benito Novas, Founder and Owner of the Global Stem Cells Group. “We had faculty members from every corner of the globe fly in for this first-ever Middle Eastern symposium hosted by our network of educators and practitioners.”
While the event was ongoing, the Global Stem Cells Group, and international network of regenerative medicinal operations and facilities, opened a new international office in Rabat, Morocca. Dr. Sefiani, a member of the Global Stem Cells Group, will be in-charge of the office. Strategically located for outreach in North Africa, the office will serve to provide regenerative medicine supplies, as well as training in the art of regenerative medicine, to North Africa.
“We are working to expand our foothold in Middle Eastern and African regions, making this office opening an exciting time for the Global Stem Cells Group,” said Mr. Novas. “Regenerative medicine stands to revolutionize all medicine as we know it today, and North Africa is deserving of this development. We thank everyone who attended our international symposium, and look forward to training doctors in staff in the art of stem cell science.”
To complement the office opening, the Global Stem Cells Group subsidiary company, Stem Cell Training, will host a two-day regenerative medicine training in March for all interested attendees. As a hands-on, comprehensive course designed to equip all attendees with the skills and tools to harvest stem cells, interested students are asked to sign up quickly as space is limited. The course is open to international students.
For more information, or to sign-up today, visit: https://www.stemcelltraining.net/.
- Published in Press Releases
THE INTERNATIONAL SOCIETY OF STEM CELL APPLICATION TO SPONSOR 16TH INTERNATIONAL CONGRESS OF ANTI-AGING IN MADRID
Mr Benito Novas
info@stemcellsgroup.com
+1305 560 5337
THE INTERNATIONAL SOCIETY OF STEM CELL APPLICATION TO SPONSOR 16TH INTERNATIONAL CONGRESS OF ANTI-AGING IN MADRID
Madrid, Spain – The International Society of Stem Cell Application (ISSCA), a promoter of excellence and hands-on education in the field of regenerative medicine today, this week announced they will be sponsoring the 16th International Congress of Anti-Aging in Madrid, Spain from October 5th to the 7th.
To take place at Hotel NH Madrid Ventas at Calle Biarritz, 2, 28028, the Congress will focus specifically on anti-aging and how regenerative medicine stands to revolutionize the industry. This will be the largest anti-aging Congress to take place in Europe this year, with over 100 speakers confirmed from all over the world, plus 800 attendees expected at the event.
“We work year-round to sponsor and host international events that encourage doctors and educators of regenerative medicine to come together and learn about what we’ve developed in our industry,” said Mr. Benito Novas, Founder and Owner of the Global Stem Cells Group “We expect this to be the biggest Congress in Europe for 2017, and can’t wait to network with the bright minds in attendance.”
The ISSCA will be presenting new regenerative medicine training that focuses on providing doctors with skills in pain management using stem cells today. They will also present training with an emphasis on Gynecology Cosmetology, to be held in Madrid February 24th and 25th of 2018. The training will allow doctors to incorporate more than 12 new protocols into their practice to treat regenerative diseases and improve aesthetic conditions.
“We are part of the vanguard of regenerative medicine, and we work to ensure through our Stem Cell Training program that we share the newest and most effective practices with the medical community today,” said Mr. Novas. “Our team oversees hands-on, immersive training and education that will equip all students with the skills and tools they need to bring regenerative medicine to their facilities today. Spread the word, and consider signing up with us for a course this February.”
The ISSCA two-day course is available to doctors from anywhere in the world. Space is limited, so interested students are encouraged to sign up quickly before the class fills up. A fully trained team of ISSCA doctors will oversee the course and provide support to all students part of the training.
For more information, or to sign up for the two-day course in Madrid this February, visit: https://cursocelulasmadre.com/.
- Published in Press Releases
THE ISSCA RELEASES OFFICIAL AGENDA FOR 5TH INTERNATIONAL REGENERATIVE MEDICINE SYMPOSIUM
THE ISSCA RELEASES OFFICIAL AGENDA FOR 5TH INTERNATIONAL REGENERATIVE MEDICINE SYMPOSIUM
Morocco – The International Society for Stem Cell Application (ISSCA), a leader in promoting excellence and setting standards in the field of publication, research, related education and certification in Regenerative Medicine, this week officially released a detailed scheduling for their forthcoming 5th International Regenerative Medicine Symposium, to be held on September 30, 2017 at the Hotel Sofitel Rabat in Morocco.
Focusing on the official event theme, “Outstanding challenge: Delivering the promise of stem cell therapies,” the symposium will begin with the welcoming and announcement of Dr. Benito Novas, the Founder and Owner of the Global Stem Cells Group.
“ISSCA continues to deliver international Regenerative Medicine Symposiums around the world, with this forthcoming event to be our first in Africa,” said Mr. Benito Novas, Founder and Owner of Global Stem Cells Group. “After holding four symposiums in Latin America, our first African event will bring a level of speakers and lectures the likes of which have never been seen.”
Following Mr. Novas’ introduction, Daeyong Kim, PhD, will present “Stem Cells: A powerful tool in modern biomedical research,” followed by Himanshu Bansal, MD, presenting, “Cell therapies for neurological diseases.” After that, the symposium welcomes Ernesto Delgado Cidranes, PhD, speaking on, “Stem Cells: Relieving pain, restoring function, and generating hope,” followed by Dr. Martiza Novas discussing, “Fundementals of stem cell biology and clinical applicatins.” The morning session concludes with a panel discussion.
The afternoon features talks from Joseph R. Purita, MD, with “Stem Cells and PRP to treat Orthopedic Conditions,” Amine Rafik, MD, PhD, on “The Role of Adipose Derived Stem Cells in the Wounds Healing,” concluding with Dr. Novas and the “Overview of the US and European Policy and Regulations on Stem Cell Research and Therapies.”
ISSCA will announce their 2018 symposium information soon. Check out their next event at: www.stemcellconference.org.
- Published in Press Releases
THE INTERNATIONAL SOCIETY FOR STEM CELL APPLICATION TO SPONSOR REGENERATIVE MEDICINE EVENT
THE INTERNATIONAL SOCIETY FOR STEM CELL APPLICATION TO SPONSOR REGENERATIVE MEDICINE EVENT
Barcelona, Spain – The International Society of Stem Cell Application (ISSCA), an international organization and educational system that promotes the study and expansion of regenerative medicine in our world today, this week announced they will be officially sponsoring the 7th International Conference on Tissue Engineering & Regenerative Medicine to take place from October 2 to the 4 in Barcelona, Spain.
As an internationally regarded event that presents attendees with the ability to meet with some of the most important regenerative medical minds of our time, like practitioner Jose Purita of the Global Stem Cells Group, the International Conference will feature dozens of speakers with unique takes on Tissue Engineering and Regenerative Medicine today.
“As we work to establish our organization as a global standard for regenerative medicine in our world, we want to sponsor and collaborate with as many doctors, educators, and groups as possible along the way,” said Mr. Benito Novas, Founder and Owner of Global Stem Cells Group. “We are thrilled to be sponsoring such a respected symposium event this weekend, and look forward to networking with the incredible minds in attendance.”
ISSCA has sponsored and hosted more than 10 events thus far in 2017. The organization is working to legitimize themselves as a reference for all regenerative medical practitioners around the world.
Right now, ISSCA hosts an International Regenerative Medicine Certification course for any physician who wants to add regenerative medicine to their practice. With a presence in more than 25-countries, interested attendees can check for their nearest city to an ISSCA training course here: https://www.stemcelltraining.net/.
To view past, present, and future events sponsored and hosted by ISSCA, visit: https://stemcellconference.org/
- Published in Press Releases